Corrigendum to Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection [Biochem. Biophys. Res. Commun. 423 (2012) 867-872]

Chayanee SetthapramoteTadahiro SasakiOrapim PuipromKriengsak LimkittikulPannamthip PitaksajjakulChonlatip PipattanaboonMikiko SasayamaPornsawan LeuangwutiwongWeerapong PhumratanaprapinSupat ChamnachananTeera KusolsukAkanitt JittmittraphapAzusa AsaiJuan Fernando AriasItaru HiraiMotoki KuharaYoshinobu OkunoTakeshi KurosuPongrama RamasootaKazuyoshi IkutaMahidol UniversityOsaka UniversityMedical & Biological Laboratories Co, LtdThe Research Foundation for Microbial Diseases of Osaka UniversityJapan International Cooperation Agency2018-10-192018-10-192013-03-01Biochemical and Biophysical Research Communications. Vol.432, No.1 (2013), 200-201109021040006291X2-s2.0-84890572520https://repository.li.mahidol.ac.th/handle/20.500.14594/31361Mahidol UniversityBiochemistry, Genetics and Molecular BiologyCorrigendum to Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection [Biochem. Biophys. Res. Commun. 423 (2012) 867-872]ErratumSCOPUS10.1016/j.bbrc.2013.01.107